[PHARMA] YoY Annualized Quarter Result on 30-Sep-2008 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
24-Nov-2008
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2008
Quarter
30-Sep-2008 [#3]
Profit Trend
QoQ- -11.03%
YoY- 24.2%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
Revenue 1,537,593 1,336,309 1,302,520 1,303,204 1,188,221 1,054,569 922,962 8.87%
PBT 75,757 64,217 71,930 88,137 72,434 37,136 55,220 5.40%
Tax -21,620 -21,201 -19,116 -30,154 -25,406 -14,190 -17,949 3.14%
NP 54,137 43,016 52,814 57,982 47,028 22,945 37,270 6.41%
-
NP to SH 53,620 43,520 51,038 56,322 45,348 21,298 34,520 7.61%
-
Tax Rate 28.54% 33.01% 26.58% 34.21% 35.07% 38.21% 32.50% -
Total Cost 1,483,456 1,293,293 1,249,705 1,245,221 1,141,193 1,031,624 885,692 8.97%
-
Net Worth 464,307 424,715 407,610 374,390 335,831 323,006 272,364 9.29%
Dividend
30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
Div - 67,041 38,514 25,672 21,390 16,399 19,185 -
Div Payout % - 154.05% 75.46% 45.58% 47.17% 77.00% 55.58% -
Equity
30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
Net Worth 464,307 424,715 407,610 374,390 335,831 323,006 272,364 9.29%
NOSH 106,983 106,981 106,984 106,968 106,952 106,955 102,778 0.67%
Ratio Analysis
30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
NP Margin 3.52% 3.22% 4.05% 4.45% 3.96% 2.18% 4.04% -
ROE 11.55% 10.25% 12.52% 15.04% 13.50% 6.59% 12.67% -
Per Share
30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
RPS 1,437.23 1,249.11 1,217.49 1,218.30 1,110.98 985.99 898.01 8.14%
EPS 50.12 40.68 47.71 52.65 42.40 19.91 33.59 6.89%
DPS 0.00 62.67 36.00 24.00 20.00 15.33 18.67 -
NAPS 4.34 3.97 3.81 3.50 3.14 3.02 2.65 8.56%
Adjusted Per Share Value based on latest NOSH - 106,969
30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
RPS 106.68 92.72 90.37 90.42 82.44 73.17 64.04 8.87%
EPS 3.72 3.02 3.54 3.91 3.15 1.48 2.40 7.57%
DPS 0.00 4.65 2.67 1.78 1.48 1.14 1.33 -
NAPS 0.3222 0.2947 0.2828 0.2598 0.233 0.2241 0.189 9.29%
Price Multiplier on Financial Quarter End Date
30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
Date 30/09/11 30/09/10 30/09/09 30/09/08 28/09/07 29/09/06 30/09/05 -
Price 5.90 4.98 4.09 3.24 3.27 3.98 4.95 -
P/RPS 0.41 0.40 0.34 0.27 0.29 0.40 0.55 -4.77%
P/EPS 11.77 12.24 8.57 6.15 7.71 19.99 14.74 -3.67%
EY 8.49 8.17 11.66 16.25 12.97 5.00 6.79 3.79%
DY 0.00 12.58 8.80 7.41 6.12 3.85 3.77 -
P/NAPS 1.36 1.25 1.07 0.93 1.04 1.32 1.87 -5.16%
Price Multiplier on Announcement Date
30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 30/09/05 CAGR
Date 01/11/11 04/11/10 13/11/09 24/11/08 22/11/07 13/11/06 22/11/05 -
Price 5.90 4.92 3.93 3.35 3.42 3.65 4.82 -
P/RPS 0.41 0.39 0.32 0.27 0.31 0.37 0.54 -4.48%
P/EPS 11.77 12.09 8.24 6.36 8.07 18.33 14.35 -3.24%
EY 8.49 8.27 12.14 15.72 12.40 5.46 6.97 3.34%
DY 0.00 12.74 9.16 7.16 5.85 4.20 3.87 -
P/NAPS 1.36 1.24 1.03 0.96 1.09 1.21 1.82 -4.73%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment